Dazcef T 250mg/31.25mg Injection
Marketer
Dazzle Healthcare
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Dazcef T 250mg/31.25mg Injection
Ceftazidime/Tazobactam 250mg/31.25mg injection is a dual-action antibiotic. This medication combats a range of bacterial infections by inhibiting microbial proliferation. Administration must be overseen by a qualified medical practitioner. Complete the prescribed treatment regimen; premature cessation may compromise efficacy. Report any missed doses. Typical side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe side effects require immediate medical attention. Seek emergency care for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Inform your doctor of all current medications, including over-the-counter drugs. Pregnant or lactating individuals should consult their physician before use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing, avoid driving if experiencing drowsiness or dizziness. Adequate rest, balanced nutrition, and hydration contribute to recovery. Your physician may order blood tests to monitor therapeutic response.
Uses of Dazcef T 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Dazcef T 250mg/31.25mg Injection:
Administering this medication will be handled by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Dazcef T 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Dazcef T 250mg/31.25mg Injection:
Administering this medication will be handled by your physician or their designated nurse. Self-medication is strictly prohibited.
How Dazcef T 250mg/31.25mg Injection works:
Ceftriaxone/Tazobactum injection (Dazcef T 250mg/31.25mg) combines the antibiotic Ceftriaxone with the beta-lactamase inhibitor Tazobactum. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Tazobactum counteracts bacterial resistance mechanisms, thereby boosting Ceftriaxone's antibacterial effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concurrent use of Dazcef T 250mg/31.25mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Dazcef T 250mg/31.25mg Injection is generally deemed safe. Preclinical trials in animals revealed minimal or no harm to the fetus; however, clinical data from human trials are scarce.
Breast feedingCAUTION
Administering Dazcef T 250mg/31.25mg Injection to breastfeeding mothers requires careful consideration. Mothers should discontinue breastfeeding throughout the treatment course and until the medication is fully cleared from their system.
DrivingUNSAFE
The administration of Dazcef T 250mg/31.25mg Injection can induce drowsiness, visual disturbances, and dizziness. Operating a vehicle is inadvisable if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Dazcef T 250mg/31.25mg Injection to individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
The injectable formulation of Dazcef T (250mg/31.25mg) requires careful administration in individuals with significant hepatic impairment; dosage modification may be necessary. A physician's consultation is advised. Altering the dose of Dazcef T (250mg/31.25mg) injection is unnecessary for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Dazcef T 250mg/31.25mg Injection :
Omit a Dazcef T 250mg/31.25mg Injection dose? Seek medical advice immediately.
Facts to Know About Dazcef T 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently